Pancreatic Cancer Research

ResearcherTokyo Women's Medical UniversityActive in the last 2 years

Toshihiro Yamaguchi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5458-5345; OpenAlex author ID A5103696220. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

  1. HIFU induces reprogramming of the tumor immune microenvironment in a pancreatic cancer mouse model. Co-author DOI 10.1007/s00795-025-00419-1↗
  2. Fibroblast inhibition by tocilizumab enabled gemcitabine/nab-paclitaxel rechallenge for pancreatic cancer. Co-author DOI 10.1111/cas.15929↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ken Masamune · 1 shared paper, 2025 · strength 0.30
  2. Shuichi Mitsunaga · 1 shared paper, 2023 · strength 0.15
  3. Kazunori Aoki · 1 shared paper, 2023 · strength 0.15
  4. Kazuo Watanabe · 1 shared paper, 2023 · strength 0.15
  5. Mitsuhito Sasaki · 1 shared paper, 2023 · strength 0.15
  6. Masafumi Ikeda · 1 shared paper, 2023 · strength 0.15
  7. Hiroshi Imaoka · 1 shared paper, 2023 · strength 0.15
  8. Hiroyuki Tsunoda · 1 shared paper, 2023 · strength 0.15
  9. Atsushi Ochiai · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.